Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. UPLOAD Other SEC-generated Letter
  2. 8-K Event Other events
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. S-3 Offering Registration Statement
  5. 8-K Event Results of operations
  6. 10-Q Report Quarterly Report
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 4 Open-market sale Chief Financial Officer sold 12,255 shares at an average $2.72 ($33,381)
  12. 4 Open-market sale SVP, Chief Scientific Officer sold 13,884 shares at $2.69 ($37,334)
  13. 4 Open-market sale CEO sold 55,511 shares at $2.69 ($149,264)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 41 · 801 filings